{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:24:29Z","timestamp":1788837869142,"version":"build-2803163510"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":243,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["304272\/2012-4"],"award-info":[{"award-number":["304272\/2012-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","award":["APQ-04625-10"],"award-info":[{"award-number":["APQ-04625-10"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Psychopharmacol Clin Exp"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1002\/hup.2450","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T09:33:49Z","timestamp":1420796029000},"page":"52-56","source":"Crossref","is-referenced-by-count":30,"title":["Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment"],"prefix":"10.1002","volume":"30","author":[{"given":"Antonio L.","family":"Teixeira","sequence":"first","affiliation":[{"name":"Interdisciplinary Laboratory of Medical Investigation, School of Medicine; Federal University of Minas Gerais; Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael T.","family":"de Souza","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroscience, LIM-27; Institute and Department of Psychiatry, University of Sao Paulo; Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V.","family":"Zanetti","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroscience, LIM-27; Institute and Department of Psychiatry, University of Sao Paulo; Sao Paulo Brazil"},{"name":"Laboratory of Psychiatric Neuroimaging, LIM-21; Institute and Department of Psychiatry, University of Sao Paulo; Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre R.","family":"Brunoni","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroscience, LIM-27; Institute and Department of Psychiatry, University of Sao Paulo; Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo F.","family":"Busatto","sequence":"additional","affiliation":[{"name":"Laboratory of Psychiatric Neuroimaging, LIM-21; Institute and Department of Psychiatry, University of Sao Paulo; Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Pathophysiology Branch; National Institute of Mental Health, NIH; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner F.","family":"Gattaz","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroscience, LIM-27; Institute and Department of Psychiatry, University of Sao Paulo; Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Machado-Vieira","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroscience, LIM-27; Institute and Department of Psychiatry, University of Sao Paulo; Sao Paulo Brazil"},{"name":"Experimental Therapeutics and Pathophysiology Branch; National Institute of Mental Health, NIH; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,9]]},"reference":[{"issue":"2","key":"10.1002\/hup.2450-BIB0001|hup2450-cit-0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder","volume":"261","author":"Barbosa","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1-3","key":"10.1002\/hup.2450-BIB0002|hup2450-cit-0002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2011.12.034","article-title":"Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers","volume":"137","author":"Barbosa","year":"2012","journal-title":"J Affect Disord"},{"issue":"2-3","key":"10.1002\/hup.2450-BIB0003|hup2450-cit-0003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000356539","article-title":"The immunology of bipolar disorder","volume":"21","author":"Barbosa","year":"2014","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"10.1002\/hup.2450-BIB0004|hup2450-cit-0004","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.pnpbp.2008.01.006","article-title":"TNF-alpha as a molecular target in bipolar disorder","volume":"32","author":"Brietzke","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1002\/hup.2450-BIB0005|hup2450-cit-0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2014.04.005","article-title":"An updated meta-analysis of oxidative stress markers in bipolar disorder","author":"Brown","year":"2014","journal-title":"Psychiatry Res"},{"issue":"7","key":"10.1002\/hup.2450-BIB0006|hup2450-cit-0006","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00213-013-3322-3","article-title":"Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial","volume":"231","author":"Brunoni","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1002\/hup.2450-BIB0007|hup2450-cit-0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000148197","article-title":"Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia","volume":"15","author":"Coelho","year":"2008","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10.1002\/hup.2450-BIB0008|hup2450-cit-0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","article-title":"Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis","volume":"54","author":"Diez-Ruiz","year":"1995","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1002\/hup.2450-BIB0009|hup2450-cit-0009","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hup.2301","article-title":"Levels of TNF-alpha, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder","volume":"28","author":"Doganavsargil-Baysal","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"10.1002\/hup.2450-BIB0010|hup2450-cit-0010","volume-title":"Structured Clinical Interview for DSM-IV Clinical Version (SCID-I\/CV)","author":"First","year":"1997"},{"issue":"8","key":"10.1002\/hup.2450-BIB0011|hup2450-cit-0011","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1017\/S146114571000146X","article-title":"Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis","volume":"14","author":"Gigante","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1002\/hup.2450-BIB0012|hup2450-cit-0012","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1440-1819.2008.01918.x","article-title":"Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder","volume":"63","author":"Grassi-Oliveira","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1002\/hup.2450-BIB0013|hup2450-cit-0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2014.03.016","article-title":"Neuroinflammation in bipolar disorder - A [11C]-(R)-PK11195 positron emission tomography study","author":"Haarman","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1002\/hup.2450-BIB0014|hup2450-cit-0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1002\/hup.2450-BIB0015|hup2450-cit-0015","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1002\/hup.2450-BIB0016|hup2450-cit-0016","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jpsychires.2011.08.003","article-title":"Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia","volume":"45","author":"Hope","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1002\/hup.2450-BIB0017|hup2450-cit-0017","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1002\/hup.2450-BIB0018|hup2450-cit-0018","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.psyneuen.2012.05.005","article-title":"Venlafaxine inhibits upregulation of plasma tumor necrosis factor-alpha (TNF--alpha in the Chinese patients in major depressive disorder: a prospective longitudinal study","volume":"38","author":"Li","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl 2","key":"10.1002\/hup.2450-BIB0019|hup2450-cit-0019","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1399-5618.2009.00714.x","article-title":"The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis","volume":"11","author":"Machado-Vieira","year":"2009","journal-title":"Bipolar Disord"},{"issue":"2","key":"10.1002\/hup.2450-BIB0020|hup2450-cit-0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/15622975.2013.830775","article-title":"Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach","volume":"15","author":"Machado-Vieira","year":"2014","journal-title":"World J Biol Psychiatry"},{"key":"10.1002\/hup.2450-BIB0021|hup2450-cit-0021","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neubiorev.2008.10.005","article-title":"Evidence for a cytokine model of cognitive functions","volume":"33","author":"McAfoose","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"10.1002\/hup.2450-BIB0022|hup2450-cit-0022","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013a","journal-title":"J Psychiatr Res"},{"issue":"1-2","key":"10.1002\/hup.2450-BIB0023|hup2450-cit-0023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013b","journal-title":"J Affect Disord"},{"key":"10.1002\/hup.2450-BIB0024|hup2450-cit-0024","doi-asserted-by":"crossref","DOI":"10.1021\/cn500038f","article-title":"Effects of Lithium on Inflammation","author":"Nassar","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1002\/hup.2450-BIB0025|hup2450-cit-0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O'Brien","year":"2006","journal-title":"J Affect Disord"},{"key":"10.1002\/hup.2450-BIB0026|hup2450-cit-0026","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dominguez","year":"2007","journal-title":"Bipolar Disord"},{"issue":"4","key":"10.1002\/hup.2450-BIB0027|hup2450-cit-0027","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mds.25752","article-title":"Palotder: phasic difPlasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease","volume":"29","author":"Rocha","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"10.1002\/hup.2450-BIB0028|hup2450-cit-0028","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1517\/17530059.2013.734807","article-title":"Novel biomarkers for bipolar disorder","volume":"7","author":"Teixeira","year":"2013","journal-title":"Expert Opin Med Diagn"},{"issue":"1-2","key":"10.1002\/hup.2450-BIB0029|hup2450-cit-0029","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2011.08.022","article-title":"Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder","volume":"136","author":"Tsai","year":"2012","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1002\/hup.2450-BIB0030|hup2450-cit-0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"key":"10.1002\/hup.2450-BIB0031|hup2450-cit-0031","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity, and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Brit J Psychiatry"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2450","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/hup.2450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T17:57:58Z","timestamp":1625162278000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2450"}},"subtitle":["sTNFRs AND LITHIUM IN BIPOLAR DISORDER"],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"URL":"https:\/\/doi.org\/10.1002\/hup.2450","relation":{},"ISSN":["0885-6222"],"issn-type":[{"value":"0885-6222","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}